Thank you @baldwin.senate.gov & Sen. Susan Collins for introducing S. 4283 to reauthorize the Public Health and Bio-Preparedness Workforce Loan Repayment Programs to strengthen the ID, HIV & public health workforce.
IDSA & @hivma.bsky.social call on Congress to swiftly reauthorize: bit.ly/4vyUlnz
Video
Data-driven modelling of long-term CD4 cell recovery trajectories under modern antiretroviral therapy in people living with HIV
✅ Just Accepted
🔗 https://bit.ly/4tvU6YL
IDSA
Come learn about GLPs in PWH this Tuesday! Sign up using the link below!
What a gift to discuss a complex case during ID Grand Rounds with this amazing colleague!!!
Be sure to sign up for this AMAZING conference with all the heavy hitters in the field of HIV Medicine. Very practical for clinicians caring for PWH.
www.iasusa.org/events/virtu...
WeRateDogs
www.merck.com/news/fda-app...
Low yield of blood cultures after end-of-therapy of an episode of infective endocarditis: a twelve years’ experience from a referral centre.
✅ Just Accepted
🔗 bit.ly/4cnJJQT
www.iasusa.org
www.merck.com
IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with resistance to doravirine IDVYNSO is the fir...
The prospective, randomized, multicenter A5391 trial found that switching from INSTI- and TAF-containing antiretroviral therapy to an NNRTI, with or withou
Webinar on Tuesday, May 5: Darcy Wooten, MD, and Roger Bedimo, MD, MS, discuss the role of GLP-1 receptor agonists in people with HIV—featuring emerging evidence and real-world clinical insights. 10:00 AM – 11:15 AM PT. www.iasusa.org/events/webin...
